Skip to content

Viatris VTRS Total Assets

Total Assets at other companies

Pfizer logo
PfizerPFE
$207.62B-0.2%
McKesson logo
McKessonMCK
$82.32B+9.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$1.42B+10.0%
Cencora logo
CencoraCOR
$81.65B+14.7%
AMP
Amphastar PharmaceuticalsAMPH
$1.65B+1.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$141.13M+38.0%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's total assets?
Viatris (VTRS) reported total assets of $36.83B in Q1 2026.
How has Viatris's total assets changed year-over-year?
Viatris's total assets decreased by 4.3% year-over-year, from $38.47B to $36.83B.
What is the long-term trend for Viatris's total assets?
Over 5 years (2020 to 2025), Viatris's total assets has grown at a -9.6% compound annual growth rate (CAGR), from $61.55B to $37.19B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.